Table 1 |
||||
|
Descriptive statistics of clinical trial, placebo arm MS patients derived from the open data set of the SLCMSR and included in "Individual Risk Profile" OLAP-tool, version 2.0.0, divided by the four different courses CIS clinically isolated syndrome, RR relapsing remitting, SP secondary progressive and PP primary progressive. |
||||
|
Disease subtype |
||||
|
|
||||
|
Database patient characteristics |
CIS |
RR |
SP |
PP |
|
|
||||
|
No. of patients |
124 |
460 |
455 |
20 |
|
Sex ratio (m/f) |
0.38 |
0.41 |
0.69 |
0.82 |
|
Age at onset (Median and 5%- and 95%- percentile) |
30 [19;40] |
29 [17;41] |
29 [18;45] |
37 [19;57] |
|
Baseline EDSS (Median and 5%- and 95%- percentile) |
1.5 [0.0;5.0] |
2.5 [1.0;5.5] |
5.5 [3.0;6.5] |
3.5 [1.5;6.0] |
|
Duration (months) (Median and 5%- and 95%- percentile) |
2 [0;104] |
66 [7;225] |
148 [40;341] |
50 [11;190] |
|
Relapses last 12 months: no relapse |
5 |
47 |
256 |
6 |
|
Relapses last 12 months: 1 relapse |
115 |
131 |
97 |
4 |
|
Relapses last 12 months: 2 or more relapses |
0 |
132 |
36 |
1 |
|
Relapses last 12 months: unknown |
4 |
150 |
66 |
9 |
|
|
||||
|
The values in brackets are the 5%- and 95%- percentile. |
||||
|
Daumer et al. BMC Medical Informatics and Decision Making 2007 7:11 doi:10.1186/1472-6947-7-11 |
||||
